Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models.
Arch Pharm (Weinheim)
; 355(5): e2100467, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35128717
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Receptors, Androgen
/
Lung Neoplasms
Limits:
Humans
/
Male
Language:
En
Journal:
Arch Pharm (Weinheim)
Year:
2022
Document type:
Article
Affiliation country:
Alemania